Comparing 3 Different Types of Pain Blocks After Laparoscopic Nephrectomy
Randomized, Prospective, Study Comparing Four-quadrant Transverses Abdominis Plane (TAP) Block, Quadratus Lumborum (QL) Block and Surgeon Infiltration Using Exparel for Postoperative Analgesia After Laparoscopic Nephrectomy
1 other identifier
interventional
120
1 country
1
Brief Summary
All three methods of postoperative analgesia have been shown to decrease postoperative pain control in nephrectomy patients, the three methods have never been compared to each other. This study aims to compare three different pain techniques proven to be beneficial in surgical nephrectomies, including the efficacy and the side effects of each technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 22, 2018
CompletedFirst Submitted
Initial submission to the registry
June 13, 2018
CompletedFirst Posted
Study publicly available on registry
July 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2020
CompletedJune 27, 2023
June 1, 2023
2.5 years
June 13, 2018
June 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Primary endpoint of this study will be VAS pain score at 24 hours
The VAS scores will be taken with both rest and movement (knee flexion) and will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 1-10 for documentation with 10 being the worst pain and 0 being no pain
Pain scores will be measured 24 hours after surgery
Primary endpoint of this study will be VAS pain score at 48 hours
Pain scores will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 1-10 for documentation with 10 being the worst pain and 0 being no pain
Pain scores will be measured 48 hours after surgery
Secondary Outcomes (1)
Secondary endpoint includes total IV and PO (By Mouth) opioid consumption at 72 hours
Opioid consumption will be measured at 1 hour post op, 24, 48, and 72 hours post op. The total amount will be recorded
Other Outcomes (4)
Average Nausea scores over 72 hours
Nausea scores will be documented at 1 hour post op, 24, 48, and 72 hours after the block. The scores will then be averaged
Average Sedation scores over 72 hours
Sedation scores will be documented at 1 hour post op, 24, 48, and 72 hours after the block. The scores will then be averaged
Subjects overall satisfaction scores
Post operatively at hour 24
- +1 more other outcomes
Study Arms (3)
Group #1
ACTIVE COMPARATORTransverses Abdominis Plane (TAP) block
Group #2
ACTIVE COMPARATORQuadratus Lumborum (QL) block
Group #3
ACTIVE COMPARATORSurgeon Infiltration using Exparel
Interventions
TAP block - Participants will get an injection of bupivacaine and exparel (numbing medicine) in the four different locations of your stomach. To be more specific, the injection placed between your oblique muscles in four different locations right after you are asleep and just before the start of surgery. Investigators will use an ultrasound machine (the machine works by taking pictures of internal organs by bouncing sound waves off them and recording the echoes) to find the abdominal muscle layers and find the correct location to inject the numbing medicine between the muscle layers.
QL block - Participants will get an injection of bupivacaine with exparel (numbing medicine) in two locations in your lower stomach. To be more specific, an injection will take place inside your quadratus lumborum muscle which is slightly deeper than your oblique muscles right after you are asleep and right before surgery. Investigators will use an ultrasound machine (the machine works by taking pictures of internal organs by bouncing sound waves off them and recording the echoes) to find the abdominal muscle layers and find the correct location to inject the numbing medicine between the muscle layers.
SI group - at the end of the surgery and just prior to you waking up, the surgeon will use a needle to inject the surgical incision site with bupivacaine and exparel (numbing medicine) spreading the medicine evenly as the needle is slowly withdrawn to make sure all layers are evenly filled with the medicine that will numb the area.
Eligibility Criteria
You may qualify if:
- Patients undergoing laparoscopic nephrectomy including partial, simple and radical nephrectomy
- ASA class 1, 2, 3 or 4
- Age 18 or older, male or female
You may not qualify if:
- Any contraindication for TAP block, QL block or surgeon infiltration
- Donor Nephrectomy
- History of substance abuse in the past 6 months
- Patients on more than 30mg po morphine equivalents of opioids, staff anesthesiologist will confirm this portion prior to enrollment.
- Any physical, mental or medical conditions which in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery.
- Known allergy to bupivacaine or Exparel
- Patients \<40kg or \>110 kg TBW
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University Hospital
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin M Backfish-White, MD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiologist
Study Record Dates
First Submitted
June 13, 2018
First Posted
July 10, 2018
Study Start
May 22, 2018
Primary Completion
November 17, 2020
Study Completion
November 17, 2020
Last Updated
June 27, 2023
Record last verified: 2023-06